LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.31623
 36.73 84.90 940 3254 0.2889 0.5795
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 36.73 84.90 1026 3254 0.3153 0.6060
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 36.73 84.90 289 3254 0.0888 0.2622
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 36.73 84.90 706 3254 0.2169 0.4958
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 38.43 84.90 995 3459 0.2876 0.5843
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 38.43 84.90 1044 3459 0.3018 0.5986
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 38.43 84.90 285 3459 0.0824 0.2541
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 38.43 84.90 739 3459 0.2136 0.4986
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 40.14 84.90 924 3682 0.2510 0.5511
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 40.14 84.90 970 3682 0.2634 0.5650
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 40.14 84.90 302 3682 0.0820 0.2628
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 40.14 84.90 728 3682 0.1977 0.4846
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 41.84 84.90 979 4003 0.2446 0.5524
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 41.84 84.90 1032 4003 0.2578 0.5672
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 41.84 84.90 311 4003 0.0777 0.2631
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 41.84 84.90 711 4003 0.1776 0.4656
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 43.55 84.90 981 4287 0.2288 0.5411
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 43.55 84.90 1024 4287 0.2388 0.5528
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 43.55 84.90 312 4287 0.0728 0.2586
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 43.55 84.90 792 4287 0.1847 0.4839
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 45.25 84.90 1087 4539 0.2394 0.5592
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 45.25 84.90 1125 4539 0.2478 0.5685
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 45.25 84.90 327 4539 0.0720 0.2648
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 45.25 84.90 800 4539 0.1762 0.4781
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 46.95 84.90 1070 4952 0.2161 0.5403
MN20160318_Q02
D08